Hasil Pencarian - Prudence Ive

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Giant bacillary angiomatosis

    Giant bacillary angiomatosis oleh Jeremy Nel, Prudence Ive, Carolina Nel

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations

    Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations oleh Lauren Richards, David C. Spencer, Jeremy S. Nel, Prudence Ive

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers

    Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers oleh Anabela C. P. Picton, Maria Paximadis, Maria Paximadis, Gemma W. Koor, Gemma W. Koor, Avani Bharuthram, Avani Bharuthram, Sharon Shalekoff, Sharon Shalekoff, Ria Lassauniere, Prudence Ive, Prudence Ive, Caroline T. Tiemessen, Caroline T. Tiemessen

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells.

    Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. oleh Kapil K Saharia, Constantinos Petrovas, Sara Ferrando-Martinez, Manuel Leal, Rafael Luque, Prudence Ive, Anne Luetkemeyer, Diane Havlir, Richard A Koup

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

    Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa oleh Denise Evans, Kamban Hirasen, Rebecca Berhanu, Given Malete, Prudence Ive, David Spencer, Sharlaa Badal-Faesen, Ian M. Sanne, Matthew P. Fox

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.

    Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. oleh Prudence Ive, William MacLeod, Nompumelelo Mkumla, Catherine Orrell, Ute Jentsch, Carole L Wallis, Wendy Stevens, Robin Wood, Ian Sanne, Debika Bhattacharya

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.

    Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. oleh Noor Dawany, Louise C Showe, Andrew V Kossenkov, Celia Chang, Prudence Ive, Francesca Conradie, Wendy Stevens, Ian Sanne, Livio Azzoni, Luis J Montaner

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa

    Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa oleh Julia K Rohr, Prudence Ive, C Robert Horsburgh, Rebecca Berhanu, Kate Shearer, Mhairi Maskew, Lawrence Long, Ian Sanne, Jean Bassett, Osman Ebrahim, Matthew P Fox

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.

    Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. oleh Julia K Rohr, Prudence Ive, C Robert Horsburgh, Rebecca Berhanu, Kate Shearer, Mhairi Maskew, Lawrence Long, Ian Sanne, Jean Bassett, Osman Ebrahim, Matthew P Fox

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

    Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance oleh Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update

    Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update oleh Nelesh P. Govender, Graeme Meintjes, Phetho Mangena, Jeremy Nel, Samantha Potgieter, Denasha Reddy, Helena Rabie, Douglas Wilson, John Black, David Boulware, Tom Boyles, Tom Chiller, Halima Dawood, Sipho Dlamini, Thomas S. Harrison, Prudence Ive, Joseph Jarvis, Alan Karstaedt, Matamela C. Madua, Colin Menezes, Mahomed-Yunus S. Moosa, Zaaheera Motlekar, Amir Shroufi, Sarah L. Stacey, Merika Tsitsi, Gilles van Cutsem, Ebrahim Variava, Michelle Venter, Rachel Wake

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: